Opisthorchiasis Treatment Market: How Is Cholangiocarcinoma Risk...

a adăugat un sunet Health

2026-07-01 07:21:10 -

Opisthorchiasis Treatment Market: How Is Cholangiocarcinoma Risk Driving Preventive Treatment Demand?

Cancer prevention-driven opisthorchiasis treatment — the recognition that O. viverrini infection causes cholangiocarcinoma (CCA) with 5,000 annual deaths in Thailand and poor prognosis creating the treatment-as-prevention market dynamic — generates the most commercially compelling therapeutic rationale, with the Opisthorchiasis Treatment Market reflecting CCA prevention as the...

0 Commentarii 0 Distribuiri 42 Views 0 previzualizare